Clinical Trial Update: T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy

View source ↗

Summary

A completed clinical trial investigating how long-term anti-TNF or interleukin-6 receptor blocker therapy affects T-cell subsets in patients with rheumatoid art…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Anti-TNF therapy
• Interleukin-6 receptor blocker therapy

Snippet

Sponsor: Szeged University | Conditions: Rheumatoid Arthritis | Status: COMPLETED